The 2026 FDA Context for Compounded GLP-1 Medications Quick Answer: Compounded GLP-1 medications are not FDA-approved, and the regulatory context tightened sharply in 2025 and 2026
GLP-1 (glucagon-like peptide-1) receptor agonist medications are a class of drugs used to treat diabetes and promote weight loss
Growing consumer awareness of obesity health risks and treatment options is driving increased consultation rates with endocrinology specialists
With 30 grams of grass-fed protein, minimal sugar and no artificial sweeteners, it kept us full for hours
Dai ZL, Li XL, Xi PB, Zhang J, Wu G, Zhu WY
What other chronic conditions do you want to treat